View in EDS

Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.
Authors: Svalheim KG; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Andresen NK; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway., Bjerre C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Norway., Jakobsen EH; Department of Oncology, Sygehus Sønderjylland, Sønderborg, Denmark., Falk RS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Naume B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kaasa S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kyte JA; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. Electronic address: jonky@ous-hf.no.
Source: Breast (Edinburgh, Scotland) [Breast] 2026 Apr; Vol. 86, pp. 104704. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41581361
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Svalheim+KG%22">Svalheim KG</searchLink>; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Andresen+NK%22">Andresen NK</searchLink>; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Bjerre+C%22">Bjerre C</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Gilje+B%22">Gilje B</searchLink>; Department of Hematology and Oncology, Stavanger University Hospital, Norway.<br /><searchLink fieldCode="AU" term="%22Jakobsen+EH%22">Jakobsen EH</searchLink>; Department of Oncology, Sygehus Sønderjylland, Sønderborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Falk+RS%22">Falk RS</searchLink>; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Naume+B%22">Naume B</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kaasa+S%22">Kaasa S</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kyte+JA%22">Kyte JA</searchLink>; Department of Clinical Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. Electronic address: jonky@ous-hf.no.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229213011%22">Breast (Edinburgh, Scotland)</searchLink> [Breast] 2026 Apr; Vol. 86, pp. 104704. <i>Date of Electronic Publication: </i>2026 Jan 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9213011 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-3080 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209609776%22">09609776 </searchLink><i>NLM ISO Abbreviation: </i>Breast <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41581361
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.breast.2026.104704
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104704
    Titles:
      – TitleFull: Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Svalheim KG
      – PersonEntity:
          Name:
            NameFull: Andresen NK
      – PersonEntity:
          Name:
            NameFull: Bjerre C
      – PersonEntity:
          Name:
            NameFull: Gilje B
      – PersonEntity:
          Name:
            NameFull: Jakobsen EH
      – PersonEntity:
          Name:
            NameFull: Falk RS
      – PersonEntity:
          Name:
            NameFull: Naume B
      – PersonEntity:
          Name:
            NameFull: Kaasa S
      – PersonEntity:
          Name:
            NameFull: Kyte JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-3080
          Numbering:
            – Type: volume
              Value: 86
          Titles:
            – TitleFull: Breast (Edinburgh, Scotland)
              Type: main
ResultId 1